Method for glycosylation of flavonoid compounds

US9364492B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9364492-B2
Application numberUS-52306508-A
CountryUS
Kind codeB2
Filing dateJan 18, 2008
Priority dateJan 19, 2007
Publication dateJun 14, 2016
Grant dateJun 14, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a method for preparing a glycoside of a flavonoid compound, which comprises the step of treating flavonoid and a glycosyl donor with an enzymatic agent having glycosylation activity and being derived from the genus Trichoderma (preferably Trichoderma viride or Trichoderma reesei ). Such a flavonoid compound includes a catechin compound or a methylated derivative thereof, and the glycosyl donor includes a carbohydrate containing a maltotriose residue (preferably maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, dextrin, γ-cyclodextrin or soluble starch). Glycosides obtained by the present invention have higher water solubility, improved taste, and increased stability. The present invention also provides novel glycosides of catechin compounds, which are obtained by the method of the present invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound represented by the following formula: wherein at least one of R 1 to R 4 represents an α-linked glucose residue or maltose residue or maltooligosaccharide residue, and each of the others represents OH; R 5 represents OH or H; and X represents H or a galloyl group, provided that the following compounds are excluded: a compound in which R 1 represents glucose, R 2 -R 4 represent OH, and R 5 and X represent H; a compound in which R 2 represents glucose, R 1 and R 3 -R 4 represent OH, and R 5 and X represent H; a compound in which R 4 represents glucose, R 1 -R 3 represent OH, and R 5 and represent H; a compound in which R 2 represents maltose, R 1 and R 3 -R 4 represent OH, and R 5 and X represent H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 represent OH, and R 5 and X represent H; a compound in which R 1 represents maltose, R 2 -R 4 represent OH, and R 5 and X represent H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 represent OH, and R 5 and X represent H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 -R 5 represent OH, and X represents H; a compound in which R 2 -R 3 represent glucose, R 1 and R 4 -R 5 represent OH, and X represents H; a compound in which R 1 and R 3 represent glucose, R 2 and R 4 -R 5 represent OH, and X represents H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 -R 5 represent OH, and X represents H; a compound in which R 4 represents glucose, R 1 -R 3 and R 5 represent OH, and X represents H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 represent OH, R 5 represents H, and X represents a galloyl group; a compound in which R 2 -R 3 represent glucose, R 1 and R 4 -R 5 represent OH, and X represents a galloyl group; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 -R 5 represent OH, and X represents a galloyl group; a compound in which R 4 represents glucose, R 1 -R 3 and R 5 represent OH, and X represents a galloyl group; a compound in which R 4 represents glucose, R 1 -R 3 represent OH, R 5 represents H, and X represents a galloyl group; a compound in which R 2 represents glucose, R 1 and R 3 -R 5 represent OH, and X represents a galloyl group; a compound in which R 2 and R 4 represent glucose, R 1 , R 3 , and R 5 represent OH, and X represents a galloyl group; a compound in which R 2 -R 3 represent glucose, R 1 and R 4 represent OH, and R 5 and X represent H; a compound in which R 1 and R 3 represent glucose, R 2 and R 4 represent OH, and R 5 and X represent H; a compound in which R 3 -R 4 represent glucose, R 1 -R 2 represent OH, and R 5 and X represent H; a compound in which R 1 and R 4 represent glucose, R 2 -R 3 represent OH, and R 5 and X represent H; a compound in which R 2 and R 4 represent glucose, R 1 , R 3 , and R 5 represent OH, and X represents H; and a compound in which R 2 and R 4 represent glucose, R 1 and R 3 represent OH, and R 5 and X represent H. 2. The compound according to claim 1 , which is selected from the group consisting of: 5-O-α-D-glucopyranosyl-(−)-epigallocatechin-3-O-gallate; 7-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(−)-epigallocatechin-3-O-gallate; 4′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(+)-catechin; 3′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(+)-catechin; and 3′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(−)-epigallocatechin-3-O-gallate. 3. A food, pharmaceutical or cosmetic composition, which comprises the compound according to claim 1 . 4. A beverage, which comprises the composition according to claim 3 . 5. A compound represented by the following formula: wherein at least one of R 1 , R 2 , and R 4 represents an α-linked glucose residue or maltose residue or maltooligosaccharide residue, and each of the others represents OH; R 3 represents a maltose residue; R 5 represents OH or H; and X represents H or a galloyl group. 6. A glycoside of a flavonoid compound selected from the following: 5-O-α-D-glucopyranosyl-(−)-epigallocatechin-3-O-gallate; 3′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(+)-catechin; and 3′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(−)-epigallocatechin-3-O-gallate. 7. A food, pharmaceutical or cosmetic composition, which comprises the compound according to claim 2 . 8. A beverage, which comprises the composition according to claim 7 .

Assignees

Inventors

Classifications

  • Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors · CPC title

  • General protective or antinoxious agents · CPC title

  • Antihyperlipidemics · CPC title

  • Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

  • Antihypertensives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9364492B2 cover?
The present invention provides a method for preparing a glycoside of a flavonoid compound, which comprises the step of treating flavonoid and a glycosyl donor with an enzymatic agent having glycosylation activity and being derived from the genus Trichoderma (preferably Trichoderma viride or Trichoderma reesei ). Such a flavonoid compound includes a catechin compound or a methylated derivat…
Who is the assignee on this patent?
Ochiai Misa, Fukami Harukazu, Nakao Masahiro, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61K31/7048. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).